Valuation: Isodiol International Inc.

Market Cap 3.91M 2.8M 2.51M 2.31M 2.09M 266M 3.98M 27.54M 11.06M 140M 10.52M 10.3M 442M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.55M 5.86M 5.39M 4.89M 622M 9.3M 64.31M 25.82M 327M 24.57M 24.04M 1.03B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
16.9
Manager TitleAgeSince
Chief Executive Officer - 2017-05-23
Corporate Officer/Principal - 2018-08-29
Director TitleAgeSince
Director/Board Member - 2017-05-23
Director/Board Member - 2018-08-29
Director/Board Member - 2018-11-20
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 128
+3.19%+11.31%+67.86%+150.58% 1,263B
-0.73%+3.56%+44.51%+85.81% 658B
+1.41%+3.24%+29.22%+107.83% 521B
+0.42%+3.20%+54.15%+67.18% 391B
+2.18%+2.93%+73.30%+45.62% 369B
+1.12%+4.52%+35.30%+58.08% 307B
+6.96%+8.86%+11.27%+36.62% 290B
+1.15%+6.09%+59.59%+77.06% 252B
+3.06%+9.38%+44.11%+119.47% 212B
Average +1.56%+5.31%+46.59%+83.14% 426.19B
Weighted average by Cap. +1.19%+6.60%+50.88%+98.31%

Financials

2018 2019
Net sales 19.14M 13.72M 12.28M 11.3M 10.24M 1.3B 19.5M 135M 54.09M 685M 51.47M 50.38M 2.16B 22.25M 15.95M 14.28M 13.14M 11.9M 1.51B 22.66M 157M 62.88M 796M 59.84M 58.57M 2.51B
Net income -36.02M -25.82M -23.12M -21.27M -19.27M -2.45B -36.7M -254M -102M -1.29B -96.89M -94.83M -4.07B -126M -90.24M -80.82M -74.34M -67.36M -8.57B -128M -887M -356M -4.51B -339M -331M -14.21B
Net Debt -15.55M -11.14M -9.98M -9.18M -8.32M -1.06B -15.84M -109M -43.95M -557M -41.82M -40.93M -1.76B 5.22M 3.74M 3.35M 3.08M 2.79M 355M 5.32M 36.77M 14.76M 187M 14.05M 13.75M 590M
Logo Isodiol International Inc.
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-
Date Price Change Volume
26-10-30 US$0.000001 0.00% 2,743
26-10-29 US$0.000001 0.00% 1,500
  1. Stock Market
  2. Stocks
  3. ISOLF Stock